Resultados de la búsqueda 71-80 of 14534 for Tyrosine

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...